New anti-clotting medication lowers risk of stroke without added bleeding

A large international study has found that asundexian, an investigational anti-clotting medication, reduces the risk of a stroke in people who recently experienced a stroke or transient ischemic attack (TIA) caused by a clot forming outside of the heart (non-cardioembolic stroke), without increasing bleeding, the most serious and feared complication of existing stroke prevention treatments.